Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

Carcinogenesis

Volumn 36, Issue 2, 2015, Pages 256-271

  Kabisch, Maria ^a   Bermejo, Justo Lorenzo ^b   Dünnebier, Thomas ^a   Ying, Shibo ^a   Michailidou, Kyriaki ^c   Bolla, Manjeet K ^c   Wang, Qin ^c   Dennis, Joe ^c   Shah, Mitul ^c   Perkins, Barbara J ^c   Czene, Kamila ^d   Darabi, Hatef ^d   Eriksson, Mikael ^d   Bojesen, Stig E ^e   Nordestgaard, Børge G ^e   Nielsen, Sune F ^e   Flyger, Henrik ^e   Lambrechts, Diether ^f,g   Neven, Patrick ^h   Peeters, Stephanie ^h   Weltens, Caroline ^h   Couch, Fergus J ⁱ   Olson, Janet E ⁱ   Wang, Xianshu ⁱ   Purrington, Kristen ^j   Chang Claude, Jenny ^a   Rudolph, Anja ^a   Seibold, Petra ^a   Flesch Janys, Dieter ^k   Peto, Julian ^l   dos Santos Silva, Isabel ^l   Johnson, Nichola ^m   Fletcher, Olivia ^m   Nevanlinna, Heli ⁿ   Muranen, Taru A ⁿ   Aittomäki, Kristiina ⁿ   Blomqvist, Carl ⁿ   Schmidt, Marjanka K ^o   Broeks, Annegien ^o   Cornelissen, Sten ^o   Hogervorst, Frans B ^o   Li, Jingmei ^p   Brand, Judith S ^d   Humphreys, Keith ^d   Guénel, Pascal ^q,r   Truong, Thérèse ^q,r   Menegaux, Florence ^q,r   Sanchez, Marie ^q,r   Burwinkel, Barbara ^a,s   Marmé, Frederik ^s   Yang, Rongxi ^a,s   Bugert, Peter ^s   González Neira, Anna ^t   Benitez, Javier ^t,u   Pilar Zamora, M ^v   Arias Perez, Jose I ^w   Cox, Angela ^x   Cross, Simon S ^x   Reed, Malcolm W ^x   Andrulis, Irene L ^y,z   Knight, Julia A ^y,aa   Glendon, Gord ^y   Tchatchou, Sandrine ^y   Sawyer, Elinor J ^ab   Tomlinson, Ian ^ac   Kerin, Michael J ^ad   Miller, Nicola ^ad   Haiman, Christopher A ^ag   Schumacher, Fredrick ^ag   Henderson, Brian E ^ag   Marchand, Loic Le ^ah   Lindblom, Annika ^d   Margolin, Sara ^d   Hooning, Maartje J ^ai   Hollestelle, Antoinette ^ai   Kriege, Mieke ^ai   Koppert, Linetta B ^ai   Hopper, John L ^aj   Southey, Melissa C ^ak   Tsimiklis, Helen ^ak   Apicella, Carmel ^aj   Slettedahl, Seth ⁱ   Toland, Amanda E ^al   Vachon, Celine ⁱ   Yannoukakos, Drakoulis ^am   Giles, Graham G ^aj,an   Milne, Roger L ^aj,an   McLean, Catriona ^ao   Fasching, Peter A ^ap,aq,ar   Ruebner, Matthias ^ap,aq   Ekici, Arif B ^ap,aq   Beckmann, Matthias W ^ap,aq   Brenner, Hermann ^a   Dieffenbach, Aida K ^a   Arndt, Volker ^a   Stegmaier, Christa ^as   Ashworth, Alan ^m   Orr, Nicholas ^m   Schoemaker, Minouk J ^m   Swerdlow, Anthony ^m   García Closas, Montserrat ^m   Figueroa, Jonine ^at   Chanock, Stephen J ^at   Lissowska, Jolanta ^au   Goldberg, Mark S ^av,aw   Labrèche, France ^ax   Dumont, Martine ^ay   Winqvist, Robert ^az   Pylkäs, Katri ^az   Jukkola Vuorinen, Arja ^ba   Grip, Mervi ^ba   Brauch, Hiltrud ^a,bb,bc   Brüning, Thomas ^bd   Ko, Yon Dschun ^be   Radice, Paolo ^bg   Peterlongo, Paolo ^bh   Scuvera, Giulietta ^bg   Fortuzzi, Stefano ^bg,bh,bi   Bogdanova, Natalia ^bj   Dörk, Thilo ^bj   Mannermaa, Arto ^bk,bl   Kataja, Vesa ^bk,bl,bm   Kosma, Veli Matti ^bk,bl   Hartikainen, Jaana M ^bk,bl   Devilee, Peter ^bn   Tollenaar, Robert A M ^bn   Seynaeve, Caroline ^ai   Van Asperen, Christi J ^bn   Jakubowska, Anna ^bo   Lubinski, Jan ^bo   Jaworska Bieniek, Katarzyna ^bo   Durda, Katarzyna ^bo   Zheng, Wei ^bp   Shrubsole, Martha J ^bp   Cai, Qiuyin ^bp   Torres, Diana ^a,bq   Anton Culver, Hoda ^br   Kristensen, Vessela ^bs,bt,bu   Bacot, François ^av   Tessier, Daniel C ^av   Vincent, Daniel ^av   Luccarini, Craig ^c   Baynes, Caroline ^c   Ahmed, Shahana ^c   Maranian, Mel ^c   Simard, Jacques ^ay   Chenevix Trench, Georgia ^af   Hall, Per ^d   Pharoah, Paul D ^w   Dunning, Alison M ^c   Easton, Douglas F ^w   Hamann, Ute ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ MAYO CLINIC   (United States)

^j KARMANOS CANCER INSTITUTE   (United States)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^m INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁿ UNIVERSITY OF HELSINKI   (Finland)

^o ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^p GENOME INSTITUTE OF SINGAPORE   (Singapore)

^q INSERM   (France)

^r UNIVERSITÉ PARIS SACLAY   (France)

^s UNIVERSITY OF HEIDELBERG   (Germany)

^t Centro Nacional de Investigaciones Oncológicas   (Spain)

^u CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^v HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^w HOSPITAL MONTE NARANCO   (Spain)

^x UNIVERSITY OF SHEFFIELD   (United Kingdom)

^y MOUNT SINAI HOSPITAL   (Canada)

^z UNIVERSITY OF TORONTO   (Canada)

^aa UNIVERSITY OF TORONTO   (Canada)

^ab GUY S HOSPITAL   (United Kingdom)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY HOSPITAL GALWAY   (Ireland)

^ae PETER MACCALLUM CANCER CENTRE   (Australia)

^af QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^ag UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ah UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ai ERASMUS MC CANCER INSTITUTE   (Netherlands)

^aj UNIVERSITY OF MELBOURNE   (Australia)

^ak UNIVERSITY OF MELBOURNE   (Australia)

^al OHIO STATE UNIVERSITY   (United States)

^am INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^an CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ao ALFRED HOSPITAL   (Australia)

^ap UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^aq Friedrich Alexander University Erlangen Nuremberg   (Germany)

^ar UNIVERSITY OF CALIFORNIA   (United States)

^as SAARLAND CANCER REGISTRY   (Germany)

^at NATIONAL CANCER INSTITUTE   (United States)

^au INSTITUTE OF ONCOLOGY   (Poland)

^av MCGILL UNIVERSITY   (Canada)

^aw ROYAL VICTORIA HOSPITAL   (Canada)

^ax UNIVERSITÉ DE MONTRÉAL   (Canada)

^ay Université Laval   (Canada)

^az UNIVERSITY OF OULU   (Finland)

^ba OULU UNIVERSITY HOSPITAL   (Finland)

^bb DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^bc UNIVERSITY OF TÜBINGEN   (Germany)

^bd RUHR UNIVERSITY BOCHUM   (Germany)

^be Johanniter Krankenhaus   (Germany)

^bf UNIVERSITY OF BONN   (Germany)

^bg NATIONAL CANCER INSTITUTE   (Italy)

^bh FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^bi Medical Faculty of the University of Bonn ^*  (Italy)

^bj HANNOVER MEDICAL SCHOOL   (Germany)

^bk UNIVERSITY OF EASTERN FINLAND   (Finland)

^bl KUOPIO UNIVERSITY HOSPITAL   (Finland)

^bm JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^bn LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bo POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bp VANDERBILT INGRAM CANCER CENTER   (United States)

^bq PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^br UNIVERSITY OF CALIFORNIA   (United States)

^bs OSLO UNIVERSITY HOSPITAL   (Norway)

^bt UNIVERSITY OF OSLO   (Norway)

^bu UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AURORA B KINASE; BACULOVIRAL IAP REPEAT CONTAINING 5; CELL CYCLE PROTEIN; CELL DIVISION CYCLE ASSOCIATED 8; INHERITED VARIANTS IN THE INNER CENTROMERE PROTEIN; PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AURKB PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; CDCA8 PROTEIN, HUMAN; ESTROGEN RECEPTOR; INCENP PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; NONHISTONE PROTEIN;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHROMOSOMAL PARAMETERS; CHROMOSOMAL PASSENGER COMPLEX; CONTROLLED STUDY; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; EXON; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; CASE CONTROL STUDY; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; PATHOLOGY; RISK;

3' UNTRANSLATED REGIONS; AURORA KINASE B; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHROMOSOMAL PROTEINS, NON-HISTONE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RISK;

EID: 84928177806     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu326     Document Type: Article

References (51)

1. Ferlay, J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Lichtenstein, P. et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
3. Peto, J. et al. (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat. Genet., 26, 411-414.
4. Ghoussaini, M. et al. (2013) Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am. J. Pathol., 183, 1038-1051.
5. Michailidou, K. et al. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet., 45, 353-361.
6. Hemminki, K. et al. (2008) Etiologic impact of known cancer susceptibility genes. Mutat. Res., 658, 42-54.
7. Carmena, M. et al. (2012) The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis. Nat. Rev. Mol. Cell Biol., 13, 789-803.
8. van der Waal, M.S. et al. (2012) Cell division control by the Chromosomal Passenger Complex. Exp. Cell Res., 318, 1407-1420.
9. Jeyaprakash, A.A. et al. (2007) Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell, 131, 271-285.
10. Ainsztein, A.M. et al. (1998) INCENP centromere and spindle targeting: identification of essential conserved motifs and involvement of heterochromatin protein HP1. J. Cell Biol., 143, 1763-1774.
11. Klein, U.R. et al. (2006) Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP. Mol. Biol. Cell, 17, 2547-2558.
12. Vader, G. et al. (2006) Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody. EMBO Rep., 7, 85-92.
13. Adams, R.R. et al. (2000) INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow. Curr. Biol., 10, 1075-1078.
14. Adams, R.R. et al. (2001) Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation. J. Cell Biol., 153, 865-880.
15. Earnshaw, W.C. et al. (1991) Analysis of the distribution of the INCENPs throughout mitosis reveals the existence of a pathway of structural changes in the chromosomes during metaphase and early events in cleavage furrow formation. J. Cell Sci., 98 (Pt 4), 443-461.
16. Fraser, A.G. et al. (1999) Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr. Biol., 9, 292-301.
17. Honda, R. et al. (2003) Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell, 14, 3325-3341.
18. Kaitna, S. et al. (2000) Incenp and an aurora-like kinase form a complex essential for chromosome segregation and efficient completion of cytokinesis. Curr. Biol., 10, 1172-1181.
19. Hümmer, S. et al. (2009) Cdk1 negatively regulates midzone localization of the mitotic kinesin Mklp2 and the chromosomal passenger complex. Curr. Biol., 19, 607-612.
20. Szafer-Glusman, E. et al. (2011) Role of Survivin in cytokinesis revealed by a separation-of-function allele. Mol. Biol. Cell, 22, 3779-3790.
21. Terada, Y. et al. (1998) AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J., 17, 667-676.
22. Adams, R.R. et al. (2001) Human INCENP colocalizes with the Aurora-B/ AIRK2 kinase on chromosomes and is overexpressed in tumour cells. Chromosoma, 110, 65-74.
23. Ambrosini, G. et al. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med., 3, 917-921.
24. Tanaka, T. et al. (1999) Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res., 59, 2041-2044.
25. Tatsuka, M. et al. (1998) Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res., 58, 4811-4816.
26. Lens, S.M. et al. (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat. Rev. Cancer, 10, 825-841.
27. Jha, K. et al. (2012) Survivin expression and targeting in breast cancer. Surg. Oncol., 21, 125-131.
28. Janssen, A. et al. (2011) Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science, 333, 1895-1898.
29. Ricke, R.M. et al. (2008) Whole chromosome instability and cancer: a complex relationship. Trends Genet., 24, 457-466.
30. Tchatchou, S. et al. (2007) Aurora kinases A and B and familial breast cancer risk. Cancer Lett., 247, 266-272.
31. Xu, Y. et al. (2004) A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol., 100, 527-537.
32. Abecasis, G.R. et al. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature, 491, 56-65.
33. Boyle, P. et al. (2005) Cancer incidence and mortality in Europe, 2004. Ann. Oncol., 16, 481-488.
34. Hemminki, K. et al. (2007) Constraints for genetic association studies imposed by attributable fraction and familial risk. Carcinogenesis, 28, 648-656.
35. Mavaddat, N. et al. (2010) Genetic susceptibility to breast cancer. Mol. Oncol., 4, 174-191.
36. The Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
37. Stranger, B.E. et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science, 315, 848-853.
38. Coetzee, S.G. et al. (2012) FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res., 40, e139.
39. The ENCODE Project Consortium (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
40. Bishop, J.D. et al. (2002) Phosphorylation of the carboxyl terminus of inner centromere protein (INCENP) by the Aurora B Kinase stimulates Aurora B kinase activity. J. Biol. Chem., 277, 27577-27580.
41. Sessa, F. et al. (2005) Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. Mol. Cell, 18, 379-391.
42. Goto, H. et al. (2006) Complex formation of Plk1 and INCENP required for metaphase-anaphase transition. Nat. Cell Biol., 8, 180-187.
43. Campa, D. et al. (2014) A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer. PLoS One, 9, e85955.
44. Huzarski, T. et al. (2013) Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer. J. Clin. Oncol., 31, 3191-3196.
45. Clark, A.J. et al. (2004) Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? Fam. Cancer, 3, 85-91.
46. Jackson, B.C. et al. (2011) Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum. Genomics, 5, 691-702.
47. Watson, M.A. et al. (1996) Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res., 56, 860-865.
48. Watson, M.A. et al. (1999) Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res., 59, 3028-3031.
49. Culleton, J. et al. (2007) Lipophilin B: a gene preferentially expressed in breast tissue and upregulated in breast cancer. Int. J. Cancer, 120, 1087-1092.
50. O'Brien, N. et al. (2002) Mammaglobin a: a promising marker for breast cancer. Clin. Chem., 48, 1362-1364.
51. Span, P.N. et al. (2004) Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J. Clin. Oncol., 22, 691-698.